Eledon Pharmaceuticals Files 8-K
Ticker: ELDN · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1404281
| Field | Detail |
|---|---|
| Company | Eledon Pharmaceuticals, Inc. (ELDN) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-K, financials
Related Tickers: ELDN
TL;DR
Eledon Pharma (ELDN) filed an 8-K on Aug 6, 2025, with SEC filings.
AI Summary
Eledon Pharmaceuticals, Inc. filed an 8-K on August 6, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Novus Therapeutics, Inc. and Tokai Pharmaceuticals Inc., is incorporated in Delaware and headquartered in Irvine, California.
Why It Matters
This filing indicates Eledon Pharmaceuticals is making disclosures and submitting financial documents to the SEC, which is standard for public companies but can signal upcoming events or financial health updates.
Risk Assessment
Risk Level: low — This is a routine SEC filing for a public company, not indicating any immediate material event or change.
Key Numbers
- 001-36620 — SEC File Number (Identifies the company's filing with the SEC.)
- 20-1000967 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Eledon Pharmaceuticals, Inc. (company) — Registrant
- August 06, 2025 (date) — Date of Report
- Novus Therapeutics, Inc. (company) — Former Company Name
- Tokai Pharmaceuticals Inc (company) — Former Company Name
- Irvine, California (location) — Principal Executive Offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as the items of disclosure, but does not specify a single triggering event in the provided text.
When was Eledon Pharmaceuticals, Inc. previously known by other names?
The company was formerly known as Novus Therapeutics, Inc. (name change on 20170511) and Tokai Pharmaceuticals Inc (name change on 20070622).
What is the principal executive office address for Eledon Pharmaceuticals, Inc.?
The principal executive offices are located at 19800 MacArthur Blvd., Suite 250, Irvine, California, 92612.
What is the SIC code for Eledon Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
The company's fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding Eledon Pharmaceuticals, Inc. (ELDN).